Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

This growth is primarily driven by the rising prevalence of cardiovascular diseases (CVDs) worldwide, alongside continuous ...

Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...

We recently compiled a list of the 10 Best Low Volatility Stocks to Invest in Now. In this article, we are going to take a ...

Read the Market Summary Here @- Global Cardiac Resynchronization Therapy (CRT) Devices Market Size Booming at Healthy CAGR of 8.4% to Touch USD 11.6 Billion by 2030 Global Cardiac Resynchronization ...

That September day was a big one for the teams at Silk Road, which makes stroke-prevention devices. But deals like this are a regular occurrence for Boston Scientific, and the Marlborough company ...

Albert K. Chin, MD, has spent over 35 years working in the field of medical technologies, having earned a great deal of ...

Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy. Now, it has resumed its work to see whether its Farapulse platform can ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...